Go back and take a look at how #s addresses that question. With smaller trial sizes, small pockets of problems may not exist or be evident. The real life trial now has 6 million (I think) people who have received the J&J vaccine. In those six million people, there will be people who have heart attacks, strokes, blood clots in the leg and lung, etc., irregardless of being vaccinated or not. The question will be if those vaccinated increase the incidence or does it stay the same . FYI, the lifetime incidence of developing a venous blood clot is about 1 in 1,000, so it's bound to happen in those six million.
Who the heck is Candace Owen and who cares about her Twitter?
If it is a story, how did the media catch wind of it so quick in light of patient privacy laws? Sounds a little fishy to me and nothing is showing up under a quick Google search.
You remember J&J was trialed against many of the variants whereas Pfizer and Moderna went up against the primary strain, right? I'm pretty sure that was explained to you several times before. Pfizer and Moderna efficacies were not tested against the variants, so your statement holds no weight until a comparable study is concluded. Feel free to report back in about half a year.